Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.82 |
| ▸ | HPGD | P15428 | 6/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.82 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.82 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.82 |
| ▸ | MAOB | P27338 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | ATM | Q13315 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA3 | P07451 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8595764 | 0.92 | ALDH1A1 (0.68) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL42693 | 0.91 | ALDH1A1 (1.00) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL29775307 | 0.91 | ALDH1A1 (1.00) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL6836549 | 0.87 | MAOB (0.64) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL203997 | 0.87 | SLC16A3 (1.00) | ALDH1A1HPGDKDM4ESLC16A3HSD17B10 | |
| SCHEMBL2028924 | 0.85 | MAOB (0.76) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL2911015 | 0.82 | MAOB (0.80) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL9643088 | 0.82 | CYP2C19 (0.58) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL51872 | 0.81 | MEN1 (0.82) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 | |
| SCHEMBL29811188 | 0.81 | MAOB (0.60) | ALDH1A1HPGDKDM4ESLC16A3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303908-B1 | FLUORESCENT CYCLIC PEPTIDES, METHODS FOR THE PREPARATION THEREOF, AND USE OF SAID PEPTIDES FOR MEASURING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-07-26 | — | — | EP | claimed |
| US-9139862-B2 | Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-09-22 | — | — | US | disclosed |
| US-20110256567-A1 | FLUORESCENT CYCLIC PEPTIDES, PREPARATION METHOD THEREOF AND USE OF THESE PEPTIDES FOR MEASURING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME | UNIVERSITE VICTOR SEGALEN - BORDEAUX 2 (FR) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256567-A1 | FLUORESCENT CYCLIC PEPTIDES, PREPARATION METHOD THEREOF AND USE OF THESE PEPTIDES FOR MEASURING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME | CTRL, PREP, PEPD | ALDH1A1 3727/4885HPGD 1294/4885KDM4E 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.